Who is sponsoring NCT02845011?

NCT02845011 is sponsored by Baqiyatallah Medical Sciences University.

What drugs are being tested in NCT02845011?

Interventions in NCT02845011: Audiovisual compression feedback, Standard Manual Chest Compression.

What condition does NCT02845011 study?

NCT02845011 studies Cardiopulmonary Arrest, Cardiopulmonary Resuscitation.

Is NCT02845011 still recruiting?

NCT02845011 is currently completed. Last updated 6 July 2018.

Last reviewed 2018-07-06 · How we verify

NCT02845011: CFA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Compression Feedback for Patients With In-hospital Cardiac Arrest

Completed NA Last updated 6 July 2018

What this trial tests

NA trial testing Audiovisual compression feedback in Cardiopulmonary Arrest in 900 participants. Completed in 30 December 2015.

Timeline

1 January 2015

Primary endpoint
15 September 2015

30 December 2015

Quick facts

Lead sponsor	Baqiyatallah Medical Sciences University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	900
Start date	1 January 2015
Primary completion	15 September 2015
Estimated completion	30 December 2015

Drugs / interventions tested

Audiovisual compression feedback
Standard Manual Chest Compression

Conditions studied

Cardiopulmonary Arrest — all drugs for Cardiopulmonary Arrest →
Cardiopulmonary Resuscitation — all drugs for Cardiopulmonary Resuscitation →

Sponsor

Baqiyatallah Medical Sciences University

Who can join

Adults 18 to 80, any sex, with Cardiopulmonary Arrest or Cardiopulmonary Resuscitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, randomized, controlled, parallel study was conducted in patients undergoing resuscitation with chest compression for in-hospital cardiac arrest (IHCA) in the mixed medical-surgical ICU's of 8 academic tertiary care hospitals in Iran. Patients randomized into 2 groups: 1) standard chest compression, 2) chest compression with real-time audio-visual feedback using the Cardio First Angel™ (CFA; INOTECH, Nubberg, Germany) device. The primary outcome was sustained return of spontaneous circulation (ROSC). Secondary outcomes were survival to ICU and hospital discharge, incidence of sternum and rib fractures.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Real-time compression feedback for patients with in-hospital cardiac arrest: a multi-center randomized controlled clinical trial.
Goharani R, Vahedian-Azimi A, Farzanegan B, Farzanegan B, et al · · 2019 · cited 41× · PMID 30693086 · DOI 10.1186/s40560-019-0357-5
A comparison of cardiopulmonary resuscitation with standard manual compressions versus compressions with real-time audiovisual feedback: A randomized controlled pilot study.
Vahedian-Azimi A, Rahimibashar F, Miller AC. · · 2020 · cited 13× · PMID 32322552 · DOI 10.4103/ijciis.ijciis_84_19
Survival to intensive care unit discharge among in-hospital cardiac arrest patients by applying audiovisual feedback device.
Goharani R, Vahedian-Azimi A, Pourhoseingholi MA, Amanpour F, et al · · 2021 · cited 4× · PMID 34716684 · DOI 10.1002/ehf2.13628

Verify or expand the search:

Other recruiting trials for Cardiopulmonary Arrest

Currently open trials in the same condition.

NCT06031623 — REBOA in Nontraumatic OHCA · NA · recruiting
NCT05784480 — Relevance of Reversible Causes During OHCA (Rebecca Study) · NA · recruiting
NCT03894059 — An Educational Program to Improve Cardiac Arrest Diagnostic Accuracy of Ambulance Telecommunicators · active not recruiting

Other Baqiyatallah Medical Sciences University trials

Trials by the same sponsor.

NCT06369688 — IDEAL SKIIN CARES Bundle to Prevent Pressure Injury · NA · not yet recruiting
NCT04463420 — Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 · NA · unknown
NCT04466280 — Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVI · NA · withdrawn
NCT04460092 — Using 32 - Gauge Needles With Lengths of 5 mm and 8 mm on Pain Post-injection, Leak and Blood Glucose · NA · unknown
NCT04376814 — Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02845011 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Baqiyatallah Medical Sciences University
Last refreshed: 6 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02845011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing